Spyre Therapeutics
SYRE
$15.45
Share price
1.01%
Change (1 day)
-58.24%
Change (1 year)
Categories
Revenue for Spyre Therapeutics (SYRE)
Revenue in 2024 (TTM): N/A
a decrease over the revenue in the year 2023 that were of $0.88 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Spyre Therapeutics from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024  | N/A | -100% |
| 2023 | $0.88 M | -61.96% |
| 2022 | $2.32 M | -87.57% |
| 2021 | $18.73 M | |
| 2020 | N/A | |
| 2019 | N/A | -100% |
| 2018 | $3.88 M | -25.29% |
| 2017 | $5.2 M | 12.45% |
| 2016 | $4.62 M | -23.94% |
| 2015 | $6.08 M | |
| 2014 | N/A |